Sign Up to like & get
recommendations!
0
Published in 2021 at "Antibiotics"
DOI: 10.3390/antibiotics10101243
Abstract: Background: Linezolid, bedaquiline, and newer fluoroquinolones are currently placed as priority Group A drugs for the treatment of drug-resistant tuberculosis. The number of reported linezolid-resistant clinical strains is still low, and the correlation of molecular…
read more here.
Keywords:
resistant tuberculosis;
profile linezolid;
linezolid resistant;
genetic profile ... See more keywords